Equivalent inhibition of in vivo platelet function by low dose and high dose aspirin treatment
- 1 April 1990
- journal article
- research article
- Published by Elsevier in Prostaglandins, Leukotrienes & Essential Fatty Acids
- Vol. 39 (4) , 319-321
- https://doi.org/10.1016/0952-3278(90)90012-a
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Prevention of recurrent idiopathic fetal growth retardation by low-dose aspirin and dipyridamolePublished by Elsevier ,2014
- Paired analysis of urinary thromboxane B2 metabolites in humansThrombosis Research, 1987
- Radioimmunoassay of 11-dehydrothromboxane B2 in human plasma and urineBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1987
- Platelet aggregation and thromboxane release induced by arachidonic acid, collagen, ADP and platelet-activating factor following low dose acetylsalicylic acid in manProstaglandins, 1986
- In vivo production of prostacyclin and thromboxane in patients with acute myocardial infarction.Heart, 1986
- Identification of 11-dehydro-TXB2 as a suitable parameter for monitoring thromboxane production in the humanProstaglandins, 1986
- PREVENTION OF PRE-ECLAMPSIA BY EARLY ANTIPLATELET THERAPYThe Lancet, 1985
- Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.Journal of Clinical Investigation, 1983
- Selective Cumulative Inhibition of Platelet Thromboxane Production by Low-dose Aspirin in Healthy SubjectsJournal of Clinical Investigation, 1982